Overview
Headquarters
San Francisco Bay Area, West Coast, Western US
Cleave Biosciences is focused on targets in cellular protein homeostasis pathways controlled by the ubiquitin proteasome and the autophagy systems, which are utilized by cancer cells in their growth and survival. Cleave Biosciences provides biotechnology services. The Company develops novel protein homeostasis inhibitors for the treatment of cancer. Cleave Biosciences serves patients in the United States. Cleave Biosciences is a California-based biopharmaceutical company that discovers and develops therapies for the treatment of cancer. Cleave Biosciences is focused on mining novel targets in cellular protein homeostasis pathways utilized by cancer cells for their growth and survival.Cleave Biosciences is a biopharmaceutical company pioneering the development of novel protein homeostasis inhibitors for the treatment of cancer. Cleave’s drug discovery team has revealed the molecular features that define several cancers that are dependent on protein homeostasis for their growth and survival. Our drugs target these protein homeostasis systems, and have the potential to transform therapeutics for people with difficult to treat solid tumors and hematologic malignancies.
